Modulation of Cell Metabolic Pathways and Oxidative Stress Signaling Contribute to Acquired Melphalan Resistance in Multiple Myeloma Cells
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Modulation of Cell Metabolic Pathways and Oxidative Stress Signaling Contribute to Acquired Melphalan Resistance in Multiple Myeloma Cells
Authors
Keywords
Stable isotope labeling by amino acids in cell culture, Mitochondria, Oxidative stress, Cell metabolism, Multiple myeloma, Enzyme metabolism, Glycolysis, STAT proteins
Journal
PLoS One
Volume 10, Issue 3, Pages e0119857
Publisher
Public Library of Science (PLoS)
Online
2015-03-14
DOI
10.1371/journal.pone.0119857
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Functional analysis of the involvement of apurinic/apyrimidinic endonuclease 1 in the resistance to melphalan in multiple myeloma
- (2014) Jiayin Xie et al. BMC CANCER
- Selective AKR1C3 inhibitors do not recapitulate the anti-leukaemic activities of the pan-AKR1C inhibitor medroxyprogesterone acetate
- (2014) F Khanim et al. BRITISH JOURNAL OF CANCER
- ProteomeXchange provides globally coordinated proteomics data submission and dissemination
- (2014) Juan A Vizcaíno et al. NATURE BIOTECHNOLOGY
- High Lactate Dehydrogenase 5 Expression Correlates with High Tumoral and Stromal Vascular Endothelial Growth Factor Expression in Gastric Cancer
- (2014) Hee Sung Kim et al. PATHOBIOLOGY
- The mTOR Pathway Controls Cell Proliferation by Regulating the FoxO3a Transcription Factor via SGK1 Kinase
- (2014) Shunsuke Mori et al. PLoS One
- mTORC2 in the center of cancer metabolic reprogramming
- (2014) Kenta Masui et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Reprogramming ovarian and breast cancer cells into non-cancerous cells by low-dose metformin or SN-38 through FOXO3 activation
- (2014) Theodore Hu et al. Scientific Reports
- Dichloroacetate inhibits aerobic glycolysis in multiple myeloma cells and increases sensitivity to bortezomib
- (2013) W Y Sanchez et al. BRITISH JOURNAL OF CANCER
- mTOR Complex 2 Controls Glycolytic Metabolism in Glioblastoma through FoxO Acetylation and Upregulation of c-Myc
- (2013) Kenta Masui et al. Cell Metabolism
- Inhibiting Aberrant Signal Transducer and Activator of Transcription Protein Activation with Tetrapodal, Small Molecule Src Homology 2 Domain Binders: Promising Agents against Multiple Myeloma
- (2013) Brent D. G. Page et al. JOURNAL OF MEDICINAL CHEMISTRY
- An Inverse Switch in DNA Base Excision and Strand Break Repair Contributes to Melphalan Resistance in Multiple Myeloma Cells
- (2013) Mirta M. L. Sousa et al. PLoS One
- Mechanisms of Nrf2 Protection in Astrocytes as Identified by Quantitative Proteomics and siRNA Screening
- (2013) James A. Dowell et al. PLoS One
- Role of aldo–keto reductase family 1 (AKR1) enzymes in human steroid metabolism
- (2013) Tea Lanišnik Rižner et al. STEROIDS
- Targeting cellular metabolism to improve cancer therapeutics
- (2013) Y Zhao et al. Cell Death & Disease
- Increased expression of VDAC1 sensitizes carcinoma cells to apoptosis induced by DNA cross-linking agents
- (2012) Ossama Sharaf el dein et al. BIOCHEMICAL PHARMACOLOGY
- l-Lactate metabolism in HEP G2 cell mitochondria due to the l-lactate dehydrogenase determines the occurrence of the lactate/pyruvate shuttle and the appearance of oxaloacetate, malate and citrate outside mitochondria
- (2012) Roberto Pizzuto et al. BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS
- A phase I dose-escalation trial of 2-deoxy-d-glucose alone or combined with docetaxel in patients with advanced solid tumors
- (2012) Luis E. Raez et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Inactivation of the HIF-1 /PDK3 Signaling Axis Drives Melanoma toward Mitochondrial Oxidative Metabolism and Potentiates the Therapeutic Activity of Pro-Oxidants
- (2012) J. Kluza et al. CANCER RESEARCH
- Influence of Dichloroacetate (DCA) on Lactate Production and Oxygen Consumption in Neuroblastoma Cells: Is DCA a Suitable Drug for Neuroblastoma Therapy?
- (2012) Marena Rebekka Niewisch et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Mortality After Incident Cancer in People With and Without Type 2 Diabetes: Impact of metformin on survival
- (2012) C. J. Currie et al. DIABETES CARE
- Aldo–keto reductases mediate constitutive and inducible protection against aldehyde toxicity in human neuroblastoma SH-SY5Y cells
- (2012) Robert C. Lyon et al. NEUROCHEMISTRY INTERNATIONAL
- Ursodeoxycholic Acid Protects Colon Cancer HCT116 Cells From Deoxycholic Acid-Induced Apoptosis by Inhibiting Apoptosome Formation
- (2012) Tohru Saeki et al. NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL
- The Warburg effect: Insights from the past decade
- (2012) Mohita Upadhyay et al. PHARMACOLOGY & THERAPEUTICS
- Eukaryotic Initiation Factor 2 Phosphorylation and Translational Control in Metabolism
- (2012) Thomas D. Baird et al. Advances in Nutrition
- Intracellular ATP levels determine cell death fate of cancer cells exposed to both standard and redox chemotherapeutic agents
- (2011) Julien Verrax et al. BIOCHEMICAL PHARMACOLOGY
- Lactate Influx through the Endothelial Cell Monocarboxylate Transporter MCT1 Supports an NF- B/IL-8 Pathway that Drives Tumor Angiogenesis
- (2011) F. Vegran et al. CANCER RESEARCH
- Lipid peroxidation and neurodegenerative disease
- (2011) Tanea T. Reed FREE RADICAL BIOLOGY AND MEDICINE
- Metformin and Cancer Risk in Diabetic Patients: A Systematic Review and Meta-analysis
- (2010) A. DeCensi et al. Cancer Prevention Research
- Emerging combination treatment strategies containing novel agents in newly diagnosed multiple myeloma
- (2009) Sagar Lonial et al. BRITISH JOURNAL OF HAEMATOLOGY
- Targeting the Fanconi Anemia/BRCA Pathway Circumvents Drug Resistance in Multiple Myeloma
- (2009) D. N. Yarde et al. CANCER RESEARCH
- MYC-Induced Cancer Cell Energy Metabolism and Therapeutic Opportunities
- (2009) C. V. Dang et al. CLINICAL CANCER RESEARCH
- Aldo-keto reductase 1C3 expression in MCF-7 cells reveals roles in steroid hormone and prostaglandin metabolism that may explain its over-expression in breast cancer
- (2009) Michael C. Byrns et al. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
- Multiple myeloma
- (2009) Marc S Raab et al. LANCET
- The aldo-keto reductase AKR1C3 contributes to 7,12-dimethylbenz(a)anthracene-3,4-dihydrodiol mediated oxidative DNA damage in myeloid cells: Implications for leukemogenesis
- (2009) Jane Birtwistle et al. MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS
- Separation and identification of trinucleotide–melphalan adducts from enzymatically digested DNA using HPLC–ESI–MS
- (2008) Dalia Mohamed et al. ANALYTICAL AND BIOANALYTICAL CHEMISTRY
- Type 5 17β-hydroxysteroid dehydrogenase/prostaglandin F synthase (AKR1C3): Role in breast cancer and inhibition by non-steroidal anti-inflammatory drug analogs
- (2008) Michael C. Byrns et al. CHEMICO-BIOLOGICAL INTERACTIONS
- The Interleukin-8 Pathway in Cancer
- (2008) D. J.J. Waugh et al. CLINICAL CANCER RESEARCH
- Is cancer a disease of abnormal cellular metabolism? New angles on an old idea
- (2008) Ralph J Deberardinis GENETICS IN MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started